Venture Capitalists

By bringing innovative therapies to the patients, Venture Capitals aim to increase the value of their companies in the most efficient and fastest possible way.

As any failure of a new drug candidate can lead to significant losses, at NUVISAN we understand the interest of derisking the compound and optionally sharing the risk with you.

With a proven track-record of customer satisfaction, NUVISAN can partner with you to increase the value of your companies from today!

contact

print

HOW CAN WE SUPPORT VENTURE CAPITAL BUILDING COMPANIES

NUVISAN can support building companies from very early stages both as Specialist consultants for R&D and as Executive Partner for Drug Discovery and Development. Our more than 400 scientists, with decades of experience in drug development, are able to perform whole integrated programs from target ID to clinical trials.

The Innovation Campus Berlin – Germany- has been running for many years to the benefit of a major pharmaceutical player. Now ICB is available to the industry for the first time from Target Identification to Candidate Selection, through to hit identification, hit-to-lead, Lead optimization, DMPK profiling and IND enabling studies under GLP where appropriate.

In addition, as Scientific consultants, we will:

  • De-risk projects and portfolios with tailor-made go/no-go experiments
  • Offer selective support from expert staff to the team during the development phase
  • Offer contributions from experts/consultants routinely working with big pharma and biotech, Regulatory Affairs, Authorities (BfARM, PEI, Ethics Commission etc.).
  • Consult on how to reach key pharma milestones for potential partnering
  • Set-up efficient research plans to gain clarity on future challenges
  • Evaluate reproducibility by wetlab activities to generate further value at high quality, in a timely manner, independent and unbiased

DUE DILIGENCE STAGE

NUVISAN can support Venture Capitals already during the Due Diligence stage, as a specialist consulting partner. We can:

  • Evaluate early ideas (proof of principle)
  • Participate in investor-company discussion to challenge the team by independent specialists from the field
  • Assess of compound specifics and chances of success, e.g. solubility etc. based on existing experiences
  • Evaluate of existing data, e.g. trustability, plausibility, necessary breadth and depth
  • Verify milestone planning/timing
  • Calculate costs for milestones, e.g. forecast reasonable (e.g. Regulatory Affairs, laboratory costs)
  • Reference to relevant experiences including failures – assuring confidentiality at all times

WHY PARTNER WITH NUVISAN?

  • FULL-SERVICE CRO/CDMO PROVIDER:
    From molecule discovery to the patient (PoC)
  • OPTIMIZED EARLY DRUG DEVELOPMENT:
    All preclinical stages under one roof (including IND enabling studies)
  • BIG PHARMA SCREENING COLLECTION:
    Access to our 3M well-characterized compound library and to our Life Science Data Base
  • STATE-OF-THE-ART EQUIPMENT:
    Fully equipped laboratories with regulatory compliant software and hardware.
  • HIGHEST SCIENTIFIC QUALITY MAXIMIZES CHANCES OF SUCCESS:
    Scientists with decades of experience in Big Pharma developing your assets/programs
  • DEDICATED & FLEXIBLE PARTNER:
    We are flexible and are open to partnership options and risk-sharing models.

 

Contact hello@nuvisan.com to learn how to start increasing the value of your company with NUVISAN.

close

Our Services & Solutions along
the Drug Development Value Chain

Please click and choose a category

Discovery

PRECLINICAL

Clinical Phase I

Clinical Phase II

Overall Services

NUVISAN Overall Services along the Value Chain

API Manufacturig
(Non-GMP / GMP)

Formulation
Development

Pharmaceutical
Analysis

Bioanalysis
(Discovery and Regulated)

Biomarkers
(exploratory & GxP)

Translational
Pharmacology

Healthy Volunteers
& Patient Studies

Clinical Trial
Supplies

Regulatory
Affairs

Backend
Services

Corporate Project
Management

NUVISAN Overall Services along the Value Chain

API Manufacturig
(Non-GMP / GMP)

Formulation
Development

Pharmaceutical
Analysis

Bioanalysis
(Discovery and Regulated)

Biomarkers
(exploratory & GxP)

Translational
Pharmacology

Healthy Volunteers
& Patient Studies

Clinical Trial
Supplies

Regulatory
Affairs

Backend
Services

Corporate Project
Management

NUVISAN Overall Services along the Value Chain

API Manufacturig
(Non-GMP / GMP)

Formulation
Development

Pharmaceutical
Analysis

Bioanalysis
(Discovery and Regulated)

Biomarkers
(exploratory & GxP)

Translational
Pharmacology

Healthy Volunteers
& Patient Studies

Clinical Trial
Supplies

Regulatory
Affairs

Backend
Services

Corporate Project
Management

NUVISAN Overall Services along the Value Chain

API Manufacturig
(Non-GMP / GMP)

Formulation
Development

Pharmaceutical
Analysis

Bioanalysis
(Discovery and Regulated)

Biomarkers
(exploratory & GxP)

Translational
Pharmacology

Healthy Volunteers
& Patient Studies

Clinical Trial
Supplies

Regulatory
Affairs

Backend
Services

Corporate Project
Management

NUVISAN Overall Services along the Value Chain

API Manufacturig
(Non-GMP / GMP)

Formulation
Development

Pharmaceutical
Analysis

Bioanalysis
(Discovery and Regulated)

Biomarkers
(exploratory & GxP)

Translational
Pharmacology

Healthy Volunteers
& Patient Studies

Clinical Trial
Supplies

Regulatory
Affairs

Backend
Services

Corporate Project
Management

NUVISAN Overall Services along the Value Chain

API Manufacturig
(Non-GMP / GMP)

Formulation
Development

Pharmaceutical
Analysis

Bioanalysis
(Discovery and Regulated)

Biomarkers
(exploratory & GxP)

Translational
Pharmacology

Healthy Volunteers
& Patient Studies

Clinical Trial
Supplies

Regulatory
Affairs

Backend
Services

Corporate Project
Management